We have received intimation from Mr. Akash Sethi (Acquirer) pursuant to Regulation 29(2) of the SEBI (SAST) Regulations regarding acquisition of 75150 Equity Share and 225450 warrants, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.6 pts less than Nifty Microcap 250 and 0.2 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mr. Akash Sethi, a promoter of Shree Pacetronix Ltd, acquired 75,150 equity shares and 2,25,450 warrants on November 14, 2025, through a preferential allotment for a total consideration of about ₹2.43 crore. This represents 7.71% of the company's fully diluted share capital post-acquisition. As a result, the combined promoter group holding (Akash Sethi along with PACs Atul Kumar Sethi, Amita Sethi, and Ashish Sethi) rose from 24.25% to 25.80% on expanded share capital (30.09% on a fully diluted basis including warrants). The company's equity share capital increased from ₹3.60 crore to ₹3.67 crore, with total diluted capital at ₹3.90 crore.
This is a promoter-led capital infusion that strengthens the promoter's stake and signals confidence in the company. For retail shareholders, it means more ownership concentration among promoters, but the preferential allotment also brings fresh capital into the business.